xix
CONTENTS
Page
Report Information i
Acknowledgement iii
Abbreviations iv
NRR Advisory Committee Members v
About the National Renal Registry vi
About MOSS viii
Participating Haemodialysis Centres x
Participating Peritoneal Dialysis Centres xiv
Participating Transplant Follow-up Centres xv
Contributing Editors xvi
Forwards xvii
CHAPTER 1: ALL RENAL REPLACEMENT THERAPY IN MALAYSIA 1
1.1: Stock and Flow 2
1.2: Treatment Provision Rate 3
CHAPTER 2: DIALYSIS IN MALAYSIA 4
2.1: Provision of Dialysis in Malaysia Registry report 5
2.2: Dialysis provision in Malaysia Centre survey report 6
2.3: Distribution of Dialysis Treatment 10
2.3.1: Gender distribution 10
2.3.2: Age distribution 11
2.3.3: Method and Location of Dialysis 13
2.3.4: Funding for dialysis treatment 14
2.3.5: Distribution of dialysis patients by sector 15
2.4: Primary Renal Disease 16
CHAPTER 3: DEATH AND SURVIVAL ON DIALYSIS 17
3.1: Death on dialysis 18
3.2: Patient survival on dialysis 20
3.3: Survival of incident patients 2000 – 2005 by centre 24
CHAPTER 4: QUALITY OF LIFE AND REHABILITATION OUTCOMES OF DIALYSIS PATIENTS IN MALAYSIA
25
A: Quality of life on dialysis 26
B: Work related rehabilitation 29
CHAPTER 5: PAEDIATRIC RENAL REPLACEMENT THERAPY 30
A: RRT provision for paediatric patients 31
B: Distribution of paediatric dialysis 33
C: Primary renal disease and 35
D: Types of Renal Transplantation 36
E: Survival analysis 36
CHAPTER 6: MANAGEMENT OF ANAEMIA IN DIALYSIS PATIENTS 38
6.1: Treatment for Anemia in Dialysis 39
6.2: Iron status on Dialysis 43
6.3: Haemoglobin outcomes on Dialysis 51
xx
CHAPTER 7: NUTRITIONAL STATUS ON DIALYSIS 56
7.1: Serum Albumin levels on Dialysis 57
7.2: Body Mass Index BMI on Dialysis 61
CHAPTER 8: BLOOD PRESSURE CONTROL AND DYSLIPIDAEMIA 65
8.1: Blood Pressure Control on dialysis 66
8.2: Dyslipidaemia in dialysis patients 74
CHAPTER 9: MANAGEMENT OF RENAL BONE DISEASE IN DIALYSIS PATIENTS 81
9.1: Treatment of renal bone disease 82
9.2: Serum calcium and phosphate control 83
CHAPTER 10: HEPATITIS ON DIALYSIS 93
